Patrick Forde
MBBCh
Professor of Oncology and Director of Thoracic Oncology
👥Biography 个人简介
Patrick Forde led CheckMate 816, the first phase III trial to establish neoadjuvant nivolumab plus chemotherapy as a new standard for resectable NSCLC, demonstrating improved event-free survival and pathologic complete response. His work transformed perioperative management of stage II-IIIA NSCLC. He continues to investigate surgical feasibility and biomarkers of neoadjuvant IO response.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Patrick Forde 的研究动态
Follow Patrick Forde's research updates
留下邮箱，当我们发布与 Patrick Forde（Johns Hopkins Sidney Kimmel Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment